Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-030805

President and CEO sold 759 shares at $11.40 ($8,653)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
AHMED NADIM President and CEO 2023-06-28 Sale −759 $11.40 $8,653 115,822 D
Open-market sales · 759 sh · avg $11.40 · $8,653
Loading xslF345X04/ownership.xml…